Curanex Pharmaceuticals Inc (CURX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$5.88

From 52W high−6.62%

Volume12511.00

Market cap$9.06M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataNov 4, 2026

Open

$5.88

From 52W high

−6.62%

Volume

12511.00

Market cap

$9.06M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.6x

P/E (TTM)

—

RSI (14)

63.5

MomentumView details →

1D Return

−6.62%

YTD Return

+1678.58%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.6x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

1.9x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−218.65%

ROA (TTM)

−206.32%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−6.62%

YTD Return

+1678.58%

1Y Return

+887.57%

RSI (14)

63.5

vs 50D SMA

+22.40%

vs 200D SMA

+226.05%

Capital & dividendView details →

Debt/Equity

0.06x

Current Ratio

45.95x

Quick Ratio

45.95x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.03

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−10.47M

Op. CF (TTM)

−12.08M

Latest newsMore news →

No recent news for CURX.

Similar companies

Brainstorm Cell Therapeutics Inc.BCLI MetaVia Inc.MTVA CalciMedica, Inc.CALC Tempest Therapeutics, Inc.TPST IN8bio, Inc.INAB BioLineRx Ltd.BLRX Find similar companies →

Latest newsMore news →

No recent news for CURX.